By indication / Tumour hypoxia
Tumour hypoxia
9 imaging agents and 2 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [18F]FMISO | F-18 | Clinical research | 19 |
| [18F]FAZA | F-18 | — | 3 |
| [18F]fluoroazomycin-2'-deoxyribofuranoside | F-18 | Preclinical | 1 |
| [18F]HX4 | F-18 | Clinical research | 1 |
| [89Zr]Zr-DFO-girentuximab | Zr-89 | Clinical research | 1 |
| [111In]DOTA-MSC3 paired with [225Ac]Ac-DOTA-MSC3 | In-111 | Preclinical | 1 |
| [18F]VM4-037 | F-18 | Research | |
| [18F]ef5 | F-18 | — | |
| [18F]FBNA | F-18 | Preclinical |
Therapy
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [225Ac]Ac-DOTA-MSC3 paired with [111In]DOTA-MSC3 | Ac-225 | Preclinical | 1 |
| [177Lu]Lu-DOTA-NI-FAPI-04 | Lu-177 | Preclinical |
Other entries
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [64Cu]Cu(ATSM) | Cu-64 | — |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.
Get in touch